Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 15, 2019 08:00 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Doses First Patient With Combination Therapy in Phase 1b/2a Trial of COTI-2

TORONTO and BOSTON, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline of...
January 08, 2019 12:20 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Enrolls Two Patients for Combination Therapy in Phase 1b/2a Trial of COTI-2

TORONTO and BOSTON, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline of...
January 03, 2019 12:32 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Reports Fiscal 2019 Second Quarter Financial and Operating Results

TORONTO and BOSTON, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT; OTCQB: COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a...
November 05, 2018 08:00 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Announces Research Partnership with St. Vincent’s University Hospital to Evaluate COTI-2

TORONTO and BOSTON, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT; OTCQB: COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a...
October 02, 2018 08:00 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Reports Fiscal 2019 First Quarter Financial and Operating Results

TORONTO and BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT; OTCQB: COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a...
September 19, 2018 08:00 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Announces Presentation on COTI-2 at 11th International Symposium on Translational Research in Oncology

TORONTO and BOSTON, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT; OTCQB: COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a...
August 29, 2018 08:00 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Reports Fiscal 2018 Fourth Quarter and Full Year Financial and Operating Results

TORONTO and BOSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT; OTCQB: COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a...
July 02, 2018 16:30 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Announces Management and Board Changes

LONDON, Ontario and BOSTON, July 02, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...
May 24, 2018 08:00 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Announces FDA Clearance of Significant Protocol Changes for COTI-2 Clinical Program

LONDON, Ontario and BOSTON, May 24, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX-V:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a...
May 17, 2018 07:30 ET | Source: Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Announces Presentation on COTI-2 at the 2018 American Society of Clinical Oncology Annual Meeting

LONDON, Ontario and BOSTON, May 17, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right